GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 94 filers reported holding GALENA BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,000 | -26.7% | 31,755 | 0.0% | 0.00% | – |
| Q2 2016 | $15,000 | -65.1% | 31,755 | 0.0% | 0.00% | – |
| Q1 2016 | $43,000 | +7.5% | 31,755 | +16.1% | 0.00% | – |
| Q4 2015 | $40,000 | -7.0% | 27,360 | 0.0% | 0.00% | – |
| Q3 2015 | $43,000 | -46.9% | 27,360 | -30.6% | 0.00% | – |
| Q3 2014 | $81,000 | -31.4% | 39,418 | +2.2% | 0.00% | – |
| Q2 2014 | $118,000 | -8.5% | 38,563 | -25.5% | 0.00% | – |
| Q1 2014 | $129,000 | – | 51,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
| Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
| Matisse Capital | 17,000 | $25,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
| EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
| OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |